Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726879 | SCV000703799 | uncertain significance | not provided | 2016-12-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000726879 | SCV000719422 | benign | not provided | 2020-10-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002315888 | SCV000739157 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-01-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV003596049 | SCV001005616 | benign | FG syndrome | 2023-12-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000726879 | SCV004165345 | likely benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | MED12: BP4, BS2 |
Prevention |
RCV003985382 | SCV004782350 | likely benign | MED12-related disorder | 2020-04-29 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV000726879 | SCV001978048 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000726879 | SCV001980607 | likely benign | not provided | no assertion criteria provided | clinical testing |